2010
Reply to: Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the ‘self (stem cell)-seeding’ nature of breast cancer disease?
Faratian D, Aitken S, Thomas J, Langdon S, Harrison D. Reply to: Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the ‘self (stem cell)-seeding’ nature of breast cancer disease? Annals Of Oncology 2010, 21: 1375. PMID: 20215137, DOI: 10.1093/annonc/mdq046.Peer-Reviewed Original Research
2009
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
Aitken S, Thomas J, Langdon S, Harrison D, Faratian D. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Annals Of Oncology 2009, 21: 1254-1261. PMID: 19858088, DOI: 10.1093/annonc/mdp427.Peer-Reviewed Original ResearchConceptsNodal diseaseReceptor statusPrimary tumorAdjuvant therapyHER2 expressionReceptor expressionInvasive primary breast carcinomasPaired lymph nodeQuantitative receptor expressionPrimary breast carcinomaPrimary breast cancerResistance to therapyExpression of molecular markersNodal metastasisBreast carcinomaLymph nodesTherapeutic resistanceBreast cancerQuantitative immunofluorescenceClinical trialsTumorImmunohistochemistryTherapyPatientsMolecular phenotypes